Qiming Venture Partners Backed Structure Therapeutics Successfully Debuts on Nasdaq
- Written by PR Newswire
SHANGHAI, Feb. 4, 2023 /PRNewswire/ -- Qiming Venture Partners' portfolio company Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical stage global biopharmaceutical company focusing on novel oral small molecule therapeutics, successfully debuts on Nasdaq on February 3 Beijing Time. It issued at $15.00 per ADS, opened at...
Read more: Qiming Venture Partners Backed Structure Therapeutics Successfully Debuts on Nasdaq